mucosis bv
Mucosis Raises US$6.9 Million In Deal With Changchun BCHT
The investment gives Changchun BCHT the license to Mucosis’ RSV candidate vaccine and the Mimopath® platform.
The investment gives Changchun BCHT the license to Mucosis’ RSV candidate vaccine and the Mimopath® platform.